Life sciences have expanded rapidly in recent years. Genetic testing particularly shows promise as a medical research tool, using databases containing thousands of digitized human genes as both products and extensions of the people they come from. With that in mind, who is entitled to own genetic data? People who volunteer their genetic material, or companies that extract it to fund research and analysis? I use the AMP v. Myriad case to discuss the ethical quandaries in determining ownership in the life sciences.

• This report represents the work of one or more WPI undergraduate students submitted to the faculty as evidence of completion of a degree requirement. WPI routinely publishes these reports on its website without editorial or peer review.

Creator

• Fiddes, Cameron

Subject

• Industry
• Learning
• Well-Being
• Innovation
• Computing
• Security
• Health
• Inclusion
• Culture
• Infrastructure

Publisher

• Worcester Polytechnic Institute

Identifier

• 66061
• E-project-042822-185020

Parola chiave

• Rhetoric
• Life sciences
• Ethics
• Genetics
• Law
• Property

Advisor

• Telliel, Yunus Dogan

Year

• 2022

UN Sustainable Development Goals

• 3 - Good Health and Well-being
• 9 - Industry, Innovation and Infrastructure
• 10 - Reducing Inequality
• 12 - Responsible Consumption and Production
• 16 - Peace, Justice, and Strong Institutions

Date created

• 2022-04-28

Resource type

• Major Qualifying Project

Major

• Professional Writing

Rights statement

• In Copyright

License

• Creative Commons BY-NC Attribution-NonCommercial 4.0 International